TD Cowen cuts target to USD 402: UnitedHealth Group stock gains 1.46 percent

Published on 10/12/2026 at 12:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 medical care ratio fell to 86.70 percent from 89.40 percent. UnitedHealth Group stock costs EUR 340.10 on October 12, 2026, versus EUR 335.20.

Key points in brief

TD Cowen cut its UnitedHealth Group target from USD 430.00 to USD 402.00 on October 9, 2026.
UnitedHealth Group reported USD 112.0 billion in second-quarter revenue and adjusted earnings per share of USD 6.38.
The medical care ratio improved to 86.70 percent from 89.40 percent in the second quarter.
UnitedHealth Group stock was at EUR 340.10 at Lang & Schwarz on October 12, 2026, 1.46 percent above the October 9 Xetra close of EUR 335.20.

Bauhaus-Poster mit geometrischen Primärfarben, Schutzschild und stilisierten menschlichen Figuren — UnitedHealth Group US91324P1021 im Bauhaus-Stil mit geometrischen Formen Primärfarben und abstrakten Menschenfiguren, Illustration mit AI erstellt.

UnitedHealth Group (ISIN US91324P1021) was trading at EUR 340.10 at Lang & Schwarz on October 12, 2026, 1.46 percent above the Xetra close of EUR 335.20 on October 9. TD Cowen cut its UnitedHealth Group price target from USD 430.00 to USD 402.00 on October 9, 2026, while maintaining a Hold rating, according to Investing.com.

Three dated operating milestones

On July 16, 2026, UnitedHealth reported USD 112.0 billion in second-quarter revenue and adjusted earnings per share of USD 6.38, according to CNBC. The company also raised its full-year adjusted earnings outlook to USD 19.50-20.00 per share.

On October 1, 2026, UnitedHealthcare introduced its 2027 Medicare Advantage plans, with more than 94 percent of Medicare-eligible individuals having access to a UnitedHealthcare plan, reported AFX News.

On October 9, 2026, TD Cowen lowered its target to USD 402.00 from USD 430.00. The cut reflects the firm discussion of 2027 outlook assumptions and a third-quarter consensus medical loss ratio of 89.90 percent, according to Investing.com.

Will the cost ratio hold?

UnitedHealth enters its next report with a clear operating test. The second-quarter medical care ratio fell to 86.70 percent from 89.40 percent a year earlier, but the improvement included USD 860 million of favorable medical reserve development, according to Zacks. That one-off contribution makes the third-quarter ratio more important than the headline improvement alone.

UnitedHealth Group will release third-quarter 2026 results on October 13, 2026, before the US market opens, and will host an 8:00 a.m. ET earnings call, according to the company release dated September 15, 2026, available through UnitedHealth Group. The release is the next scheduled date listed for the company.

Price and target reset

TD Cowen's new USD 402.00 target is 8.12 percent above the USD 371.80 primary-market reference price cited in its October 9 report. That comparison is separate from the euro quotation: the Lang & Schwarz price of EUR 340.10 was 1.46 percent above the Xetra close of EUR 335.20 on October 9. UnitedHealth Group's USD 344.5 billion market capitalization and USD 255.97 to USD 461.62 52-week range were available as of October 9, 2026.

The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.